You are on page 1of 6

Aesth Plast Surg (2013) 37:216–221

DOI 10.1007/s00266-013-0080-x

ORIGINAL ARTICLE AESTHETIC

A Modified Surgical Method of Lower-Face Recontouring


Jinghong Xu • Yijia Yu

Received: 6 September 2012 / Accepted: 12 January 2013 / Published online: 16 February 2013
 Springer Science+Business Media New York and International Society of Aesthetic Plastic Surgery 2013

Abstract hypertrophy of the temporalis muscle and masseter muscle.


Background In general, the width of the lower face is Since then, many experts have been interested in treatment
determined by four parts: the mandible, the masseter for this disharmony. Treatment of masseter muscle
muscle, the buccal fat pad, and the subcutaneous fat. In this hypertrophy varies from conservative to surgical, and the
article, we introduce a modified surgical method to reshape latter depends on the surgeon’s skill and experience [1].
the outline of round faces that have no significant over- Surgical treatment was first proposed by Gurney in 1947
growth or eversion of the lower jawbone. [2]. The procedure consists of a submandibular incision
Method The procedure includes dissection of the masse- and the removal of 3/4 to 2/3 of all muscle tissue available
ter muscle and partial lipectomy of the buccal fat pad from the muscle upper aponeurosis to the lower mandibular
through the same intraoral small incision. border [2]. In 1977, Becker [3] reported on a surgical
Results The patients were satisfied with the aesthetic intraoral approach in treating 17 patients. An internal
outcome of both the profile and frontal view. Follow-up of muscle band was removed from the hypertrophied masseter
more than 6 months shows no prospective complications. muscle in the upper insertion in the zygomatic arc and the
Conclusion This method yields an optimal aesthetic lower insertion in the mandibular angle, thus reducing the
result in patients who have a round face without significant possibility of injuring branches of the facial nerve and
overgrowth or eversion of the lower jawbone. avoiding a visible scar on the face [3].
Level of Evidence IV This journal requires that authors This article describes one typical case of idiopathic
assign a level of evidence to each article. For a full masseter muscle hypertrophy and proposes an effective
description of these Evidence-Based Medicine ratings, treatment option for these patients who have benign mas-
please refer to the Table of Contents or the online seter muscle hypertrophy and buccal fat pad hypertrophy
Instructions to Authors www.springer.com/00266. but no significant overgrowth or eversion of the lower
jawbone. Secondary masseter muscle hypertrophy, such as
Keywords Masseter muscle  Hypertrophy  parotid tumors and minor salivary gland tumors, are not
Buccal fat pad considered.

Introduction
Method
Masseter muscle hypertrophy was first described by Legg
in 1880 in the case of a 10-year-old girl with bilateral Eight female patients (age range = 24–32 years) under-
went surgery in our department between March 4, 2011 and
J. Xu (&)  Y. Yu June 20, 2012. All of the patients fit the following
Department of Plastic Surgery, The First Affiliated Hospital, conditions:
College of Medicine, Zhejiang University, Hangzhou,
Zhejiang 310003, People’s Republic of China • The patient had a strong desire to alter her facial lines
e-mail: xujinghong2008@gmail.com on both the profile and the frontal view.

123
Aesth Plast Surg (2013) 37:216–221 217

Fig. 2 The buccal fat pad will show itself after separating the
Fig. 1 A horizontal intraoral incision is made *1.5 cm in the buccal buccinator
mucosa at the bite level

• The patient’s only complaint was that her round face


generated discomfort and negative cosmetic impact;
there was no complaint of any functional disorder.
• Physical examination from intraoral and extraoral
inspection and palpation revealed the patient had
bilateral masseter muscle hypertrophy and buccal fat
pad overgrowth without further alteration, no signifi-
cant overgrowth or eversion of the mandibular angle,
no mouth opening disorder, and no other functional
disorder.
• The patient did not have any contraindications for
surgery.
Fig. 3 Partial lipectomy of the buccal fat pad
All the surgeries were performed with the patient under
local anesthesia. A horizontal intraoral incision approxi-
mately 1.5 cm in the buccal mucosa of the bite level was
made first (Fig. 1). When the buccinator was carefully and
gently separated through the incision, the buccal fat pad
showed itself (Fig. 2). The body of the buccal fat pad was
located and partial lipectomy of it was performed (Fig. 3).
The masseter muscle was detached with an elevator from
the inferior margin and posterior margin attachment point
of the mandible surface through the same incision (Fig. 4).
The incision was closed in a single plane with a 5-0
absorbable suture at the end of the procedure. A com-
pressive dressing was put in place and elastic compression
for more than 3 days (Fig. 5).
Fig. 4 The masseter muscle was detached with an elevator from the
inferior margin and posterior margin attachment point of mandible
surface
Results

For all eight patients, surgery was offered for cosmetic Discussion
reasons and no complications occurred during surgery. All
patients were satisfied with the aesthetic outcome of both According to Poch’s classification, there are ten face types.
the profile and the frontal view. Follow-up of more than Among them the oval face is recognized as the most
6 months has revealed no prospective complications beautiful, especially for Asian people. In many Chinese
(Figs. 6, 7, 8, 9, 10, 11, 12, 13). classics, the face of beauty is always described as an oval

123
218 Aesth Plast Surg (2013) 37:216–221

Fig. 5 A compressive dressing was put in place

Fig. 7 Preoperative views of a 24-year-old woman showing obvious


bilateral masseter muscle hypertrophy and mild buccal fat pad
overgrowth. Postoperative views at 6 months showing substantial
improvement of the lower face

Injection of botulinum toxin type A (BTX-A) into the


masseter muscle was first introduced by Smyth, and Moore
and Wood in 1994. In recent decades, BTX-A injection has
become a very popular way to cosmetically sculpt the
lower face because it is convenient and less invasive.
However, the results of injection can vary from subtle
thinning of the face to an extremely thin, cachectic
appearance. While treating masseter muscle hypertrophy,
BTX-A can also cause muscle weakness. It is reported that
Fig. 6 Preoperative views of a 29-year-old woman showing obvious the maximum bite force was significantly lower after
bilateral masseter muscle hypertrophy and buccal fat pad overgrowth, injection of BTX-A into the masseter muscle [5, 6].
especially in the right side of the face. Postoperative views at The traditional method for treating masseter muscle
7 months showing substantial improvement of the lower face
hypertrophy is surgical partial excision of the masseter
muscle under general anesthesia. Complications of partial
face with a round upper face, small lower face, and pointed excision include hematoma formation, facial nerve paral-
chin. In general, the shape of the lower face is determined ysis, infection, limited ability to open the mouth, and
by four parts: the masseter muscle, the buccal fat pad, the sequelae from general anesthesia [4].
mandible, and the subcutaneous fat. Dissection of the masseter muscle from the point of
The masseter muscle plays an important role in facial attachment to the bone surface can result in a cosmetic
aesthetics. The prominent masseter muscle can be consid- effect as well. Some animal models have shown that the
ered cosmetically disfiguring, especially in patients without masseter muscle will atrophy and the volume of the mas-
significant overgrowth or eversion of the mandibular angle. seter muscle will decrease after dissection [7]. Reasons for
Treatment options for masseter muscle hypertrophy range this effect can be attributed to two main points: (1) the
from simple pharmacotherapy to more invasive surgical masseter nerve stem and divisions may be injured during
reduction [1]. the dissection, which leads to atrophy of denervated

123
Aesth Plast Surg (2013) 37:216–221 219

Fig. 9 Preoperative views of a 25-year-old woman showing obvious


Fig. 8 Preoperative views of a 26-year-old woman showing bilateral bilateral masseter muscle hypertrophy and buccal fat pad overgrowth,
masseter muscle hypertrophy and obvious buccal fat pad overgrowth. especially in the left side of the face. Postoperative views at
Postoperative views at 6 months showing substantial improvement of 6.5 months showing substantial improvement of the lower face
the lower face

masseter muscle due to disuse, and (2) the blood supply of


the masseter muscle may be reduced after dissection, which
leads to muscular dystrophy [7]. More animal experiments
and clinical studies are needed to confirm the outcomes of
this method.
Buccal fat pad excision can result in aesthetic
improvement of the middle and lower face. It has been
reported that partial lipectomy of the buccal fat pad results
in an optimal result with few complications [8–10].
Our modified surgical method combines dissection of
the masseter muscle with partial lipectomy of the buccal fat
pad. There are several advantages to this method: (1) Two
procedures are performed through the same intraoral small
incision and there is no scar left on the skin after surgery.
(2) Dissection of the masseter muscle under local anes-
thesia replaces excision of the masseter muscle under
general anesthesia. This could diminish the trauma of the
surgery, avoid injury of the parotid gland, and reduce the
possibility of postoperative hemorrhage or hematoma.
Thus, the cosmetic effect will be achieved with reduced
complications.
Prospective complications of this method include
Fig. 10 Preoperative views of a 30-year-old woman showing obvious
infection, hematoma of the cheek, and asymmetry of the
bilateral masseter muscle hypertrophy and mild buccal fat pad
lower face. An unsightly bulge caused by retraction of the overgrowth. Postoperative views at 8 months showing substantial
masseter muscle was considered before we designed this improvement of the lower face

123
220 Aesth Plast Surg (2013) 37:216–221

Fig. 11 Preoperative views of a 29-year-old woman showing obvious Fig. 13 Preoperative views of a 25-year-old woman showing obvious
bilateral masseter muscle hypertrophy and mild buccal fat pad bilateral masseter muscle hypertrophy and buccal fat pad overgrowth,
overgrowth, especially in the left side of the face. Postoperative views especially in the right side of the face. Postoperative views at
at 6 months showing substantial improvement of the lower face 7 months showing substantial improvement of the lower face

method. However, we believe the incidence of this phe-


nomenon will be very low based on a great deal of litera-
ture. First, we dissect the masseter muscle at the attachment
point of the mandibular angle rather than in the main part
of the muscle. Second, 3 days of elastic compression after
surgery not only prevents bleeding, it also puts appropriate
force on the muscle. In addition, as mentioned before, the
muscle will atrophy because of the reduced blood supply
and nerve control. None of our patients experienced this
bulge of the cheek during the follow-up period.

Conclusion

The method presented here can obtain optimal aesthetic


results with few complications in patients under the fol-
lowing physical conditions: bilateral masseter muscle
hypertrophy and buccal fat pad overgrowth without further
alteration, no significant overgrowth or eversion of the
mandibular angle, and no functional disorder.

Conflict of interest The authors have no conflict of interest to


disclose.

Fig. 12 Preoperative views of a 32-year-old woman showing obvious References


bilateral masseter muscle hypertrophy and buccal fat pad overgrowth,
especially in the right side of the face. Postoperative views at 1. Rispoli DZ (2008) Benign masseter muscle hypertrophy. Braz J
6 months showing substantial improvement of the lower face Otorhinolaryngol 74(5):790–793 Erratum 74(6):949

123
Aesth Plast Surg (2013) 37:216–221 221

2. Gurney CE (1947) Chronic bilateral benign hypertrophy of the 7. Du BJ, Liu DL, Liu YS, Zheng JS, Su B (2006) Establishment of
masseter. Am J Surg 73:137–139 animal model of selectively denervated masseter in rabbits.
3. Becker HL (1977) Masseteric muscle hypertrophy and its intra- J Fourth Mil. Med. Univ China 27(10):890–893
oral surgical correction. J Oral Maxillofac Surg 5(1):28–35 8. Carbonell A, Salavert A, Planas J (1991) Resection of the buccal
4. Ham JW (2009) Masseter muscle reduction procedure with fat pad in the treatment of hypertrophy of the masseter muscle.
radiofrequency coagulation. J Oral Maxillofac Surg 67:457–463 Aesthet Plast Surg 15(3):219–222
5. Wu WT (2010) Botox facial slimming/facial sculpting: the role of 9. Stuzin JM, Wagstrom L, Kawamoto HK et al (1990) The anat-
botulinum toxin-A in the treatment of hypertrophic masseteric omy and clinical applications of the buccal fat pad. Plast Reconstr
muscle and parotid enlargement to narrow the lower facial width. Surg 85:29–37
Facial Plast Surg Clin North Am 18(1):133–140 10. Matarasso A (1991) Buccal fat pad excision: aesthetic improve-
6. Ahn KY, Kim ST (2007) The change of maximum bite force after ment of the midface. Ann Plast Surg 26(5):413–418
botulinum toxin type A injection for treating masseteric hyper-
trophy. Plast Reconstr Surg 120:1662–1666

123

You might also like